Beijing Konruns Pharmaceutical Co.,Ltd.’s Net Profit Dropped 19.5% in First Three Quarters of 2022

Beijing Konruns Pharmaceutical Co.,Ltd. (北京康辰药业股份有限公司) (603590.SH) reported a net profit of 114.5 million yuan in the first three quarters of 2022, down 19.5% year-on-year.

Meanwhile, the company posted 588 million yuan in revenue, down 1.4% year-on-year.

At the end of the reporting period, it had 3.4 billion yuan in total assets and 204.3 million yuan in total liabilities, with a liability-to-asset ratio of 6.1%.